Breaking: MERCK FAILS TO WIN FDA PANEL BACKING FOR VYTORIN HEART CLAIM! 15/12/2015 Global Media 0 Spread the word157 157SharesSpread the word157 157SharesMerck & Co should not be allowed to claim that its cholesterol-lowering drug Vytorin reduces the risk of heart attacks and strokes in […] Spread the word157 157Shares